Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis Jinming SongPeter W. Melera Original Article 09 August 2001 Pages: 339 - 346
Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies Craig A. BunnellJeffrey G. SupkoLawrence N. Shulman Original Article 28 August 2001 Pages: 347 - 355
Japanese experience with second-line chemotherapy with low-dose (60 mg/m2) docetaxel in patients with advanced non-small-cell lung cancer Toru MukoharaKoji TakedaShunichi Negoro Original Article 18 August 2001 Pages: 356 - 360
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours A. BosE. VriesJ. Vermorken Original Article 17 August 2001 Pages: 361 - 369
Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen Masato MakinoHidehiko ShojiNobuaki Kaibara Original Article 21 August 2001 Pages: 370 - 374
Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats Kataleeya P. StecklairDeborah R. HamburgerJulie L. Eiseman Original Article 18 August 2001 Pages: 375 - 382
Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase Ryan D. DeHaanEugenia M. YazlovitskayaDiane L. Persons Original Article 28 August 2001 Pages: 383 - 388
Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy Omar N. SafarjalaniXiao-Jian ZhouMahmoud H. Kouni Original Article 23 August 2001 Pages: 389 - 397
In vitro studies on the mechanisms of oxaliplatin resistance Suzanne HectorWanda Bolanowska-HigdonLakshmi Pendyala Original Article 21 August 2001 Pages: 398 - 406
Thymidine phosphorylase as a target for imaging and therapy with thymine analogs Raymond W. KleckerJerry M. Collins Original Article 17 August 2001 Pages: 407 - 412
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice Henry S. FriedmanStephen T. KeirStephen J. Waters Original Article 01 August 2001 Pages: 413 - 416
A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma Manousos M. KonstadoulakisPantelis T. AntonakisBasil X. Golematis Clinical Trial Report 13 September 2001 Pages: 417 - 420
Use of PEG-asparaginase in the treatment of patients with solid tumors João Paulo Vieira PinheiroClaudia LanversJoachim Boos Letter to the Editors 17 August 2001 Pages: 421 - 422